Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cindy A Wilson

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Breast Cancer Research : BCR|August 21, 2004
Recent translational research: microarray expression profiling of breast cancer--beyond classification and prognostic markers?Cindy A Wilson, Judy Dering
Journal of the National Cancer Institute|September 8, 2005
Evolving understanding of growth regulation in human breast cancer: interactions of the steroid and peptide growth regulatory pathwaysCindy A Wilson, Dennis J Slamon
Journal of the National Cancer Institute|December 18, 2003
Is there a role for epidermal growth factor receptor inhibitors in breast cancer prevention?Gottfried E Konecny, Cindy A Wilson, Dennis J Slamon
Breast Cancer Research and Treatment|February 3, 2007
Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type/"triple-negative" breast cancer cell lines growing in vitroRichard S Finn, Judy Dering, Charles Ginther, et al.
Breast Cancer Research : BCR|February 7, 2006
HER-2 overexpression differentially alters transforming growth factor-beta responses in luminal versus mesenchymal human breast cancer cellsCindy A Wilson, Elaina E Cajulis, Jennifer L Green, et al.
Molecular Carcinogenesis|September 23, 2003
Novel consensus DNA-binding sequence for BRCA1 protein complexesP LouAnn Cable, Cindy A Wilson, Frank J Calzone, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Breast Cancer Research : BCR|August 21, 2004
Recent translational research: microarray expression profiling of breast cancer--beyond classification and prognostic markers?Cindy A Wilson, Judy Dering
Journal of the National Cancer Institute|September 8, 2005
Evolving understanding of growth regulation in human breast cancer: interactions of the steroid and peptide growth regulatory pathwaysCindy A Wilson, Dennis J Slamon
Journal of the National Cancer Institute|December 18, 2003
Is there a role for epidermal growth factor receptor inhibitors in breast cancer prevention?Gottfried E Konecny, Cindy A Wilson, Dennis J Slamon
Breast Cancer Research and Treatment|February 3, 2007
Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type/"triple-negative" breast cancer cell lines growing in vitroRichard S Finn, Judy Dering, Charles Ginther, et al.
Breast Cancer Research : BCR|February 7, 2006
HER-2 overexpression differentially alters transforming growth factor-beta responses in luminal versus mesenchymal human breast cancer cellsCindy A Wilson, Elaina E Cajulis, Jennifer L Green, et al.
Molecular Carcinogenesis|September 23, 2003
Novel consensus DNA-binding sequence for BRCA1 protein complexesP LouAnn Cable, Cindy A Wilson, Frank J Calzone, et al.
Pageof 1